Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.39 -0.02 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aclaris Therapeutics (ACRS) Depreciation and Depletion (2014 - 2025)

Updated

Aclaris Therapeutics (ACRS) posted Depreciation and Depletion of $100,000 for Q3 2025, down 50.0% from $200,000 a year earlier and unchanged from the prior quarter.

Analysis

Aclaris Therapeutics (ACRS) Depreciation and Depletion (2014 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, Depreciation and Depletion at Aclaris Therapeutics was $400,000, down 50.0% year-over-year; for FY2024, it came in at $700,000, down 12.5% from FY2023.

  • Annual Depreciation and Depletion shows a five-year compound annual growth rate of -14.1% (FY2019 to FY2024).
  • In prior years, Aclaris Therapeutics' Depreciation and Depletion was $800,000 in FY2023 (+14.3%), $700,000 in FY2022 (-12.5%), $800,000 in FY2021 (-27.3%) and $1.1 million in FY2020 (-26.7%).
  • Quarterly Depreciation and Depletion has run from a low of $100,000 in Q4 2022 to a high of $200,000 in Q3 2024 over five years.
  • On a year-over-year basis, Depreciation and Depletion has declined in each of the last four quarters, with an average decline of 12.5% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation and Depletion in the past five years was Q4 2023, with growth of 100.0%; the weakest was Q4 2020, with a decline of 66.7%.
  • According to Business Quant data, Depreciation and Depletion for the three prior quarters was $100,000 (Q2 2025), $100,000 (Q1 2025) and $100,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aclaris Therapeutics 613.83 Mn 613.83 Mn 1.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 200,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 200,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 200,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 200,000.00
Dec 31, 2021 200,000.00
Sep 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 200,000.00
Dec 31, 2020 200,000.00
API Access

Aclaris Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ACRS&period=max&api_key=YOUR_API_KEY